This is Signify Research’s 2023 report on Breast Imaging. The report is a component of Signify Research's X-ray Market Intelligence Service.
Breast Imaging for cancer remains one of the most significant issues affecting women’s health globally. However, the COVID-19 pandemic has created a vast backlog of screening cases, with early diagnosis of cancer being missed for many women.
This report evaluates the Breast Imaging market, across all imaging modalities, including
the established mammography and tomosynthesis to technologies that are challenging,
such as ultrasound, CT and MRI imaging. Additionally Signify Research analyses the
machine learning tools that are being utilised to assist with screening, triaging and
provide a higher level of efficiency.